Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency

NCT00811785 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Menkes Disease
Occipital Horn Syndrome
Unexplained Copper Deficiency

Interventions

DRUG: Copper Histidine

Sponsor

Cyprium Therapeutics, Inc.

Collaborators

[object Object]
[object Object]